Human Organs Debate | Vivienne Parry | Opposition

OxfordUnion
4 Dec 201511:15

Summary

TLDRThis speech argues against the legalization of organ sales, asserting it would not achieve its goals and would negatively affect donation attitudes. The speaker highlights the health risks for donors, the lack of comprehensive data on donor outcomes, and the potential for exploitation, especially of the poor and vulnerable. They also point out that payment systems have not proven effective in countries like Iran and emphasize the importance of non-monetary incentives for organ donation.

Takeaways

  • 🚫 Legalizing the sale of organs is considered a backward step with potential negative impacts on society and the donation process.
  • 🏥 There are moral limits to what can be commodified in markets, and organ sales cross that ethical boundary.
  • 📈 Efforts to increase organ donation rates in Britain have been successful without resorting to payment, resulting in a 50% increase in transplanted organs.
  • 💔 The health implications for living organ donors are significant and often under-discussed, with increased risks of kidney failure and other complications.
  • 💰 The costs of paying donors for organs are not fully considered, especially the long-term health care needs that may arise for the donors.
  • 🤔 Payment for organs could lead to a transactional mindset, devaluing the altruistic nature of organ donation and potentially increasing dishonesty in donor histories.
  • 📉 The idea of organ sales being limited to kidneys is challenged, as the principle could extend to other organs with even greater risks.
  • 👶 The concept of a market in organs is compared to the abhorrence of selling children, highlighting the devaluation of human life and dignity.
  • 🏥 The current system in the UK compensates hospitals for the costs of organ transplantation, not the donors themselves.
  • 🩸 Blood donation in the UK is successful without payment, suggesting that voluntary systems can work effectively compared to mixed paid and voluntary systems in the US.
  • 🇮🇷 The example of Iran, where organ sales are legal, shows issues with coercion, exploitation of the poor, and long waiting lists for certain organs, indicating that a paid system does not necessarily solve shortages.

Q & A

  • What is the speaker's stance on legalizing the sale of organs?

    -The speaker is against legalizing the sale of organs, arguing that it would be a backward step and would not achieve its intended ends.

  • What was the purpose of the Organ Donor Task Force the speaker was a part of?

    -The Organ Donor Task Force was assembled to increase organ donation rates in Britain, which had been very low.

  • How has the infrastructure improvement impacted organ donation rates in Britain?

    -The infrastructure improvements have led to a 50% increase in transplanted organs in Britain.

  • What are the health implications for living organ donors, particularly for kidney donors?

    -Living kidney donors are 8 to 11 times more likely to end up in kidney failure compared to those with both kidneys, and they may face poorer circulatory health as they age.

  • What percentage of kidney donors in the US are lost to follow-up, and what are the implications?

    -35% of kidney donors in the US are lost to follow-up, which means the long-term health implications for these donors are not well documented or understood.

  • What are the potential complications and psychological issues faced by kidney donors?

    -20% of kidney donors have complications after surgery, and 30% suffer from psychological problems, which can be severe.

  • What was the estimated cost and benefit of paying donors $45,000 each for a kidney, according to a paper in the American Journal of Transplantation?

    -The paper suggested that paying donors $45,000 each for a kidney could eliminate the waiting list and save billions for society, but it did not account for the future health costs for the donors.

  • How does the speaker describe the attitudes towards organ donation when it becomes commercialized?

    -The speaker suggests that commercializing organ transplants can lead to a transactional view of organs as commodities, with potential for dishonesty about medical history and a lack of consideration for the donors' long-term health.

  • What are the risks associated with living liver donation?

    -There is a 1 in 200 chance of death during liver donation surgery and a 40% complication rate for living donors.

  • What is the current situation regarding children waiting for a heart transplant in the UK?

    -There are 16 children in the UK waiting for a heart transplant, and the country has run out of 'bridge to transplantation' pediatric beds.

  • How does the speaker argue that the best way to deal with organ waiting lists is not through payment to donors?

    -The speaker believes that directing money to prevent diseases like diabetes, which is the main cause of kidney failure, is a better approach than paying donors, as it addresses the root cause of the organ shortage.

  • What is the current payment system for hospitals in the UK when they perform a kidney transplant?

    -Each UK hospital that performs a kidney transplant is paid £22,000 to cover the expenses associated with the procedure.

  • What is the speaker's view on the potential unfairness of a market for organs?

    -The speaker argues that a market for organs would be unfair and exploitative, particularly towards the poor and vulnerable, and would devalue the precious gift of organ donation.

  • What is the situation with blood donation in the UK compared to the US?

    -In the UK, 40% of the population gives enough blood for all transfusion needs voluntarily, while the US has a mixed economy of paid and voluntary donations and still suffers from shortages.

  • What are the issues with the organ donation system in Iran, where payment for organs is allowed?

    -In Iran, there are issues with young women being coerced into organ donation by their families, and 50% of the donors are in poverty, highlighting the unfairness and exploitative nature of a paid organ market.

Outlines

00:00

🚫 The Ethical Dilemma of Legalizing Organ Sales

The speaker argues against the legalization of organ sales, asserting that it would not achieve its intended goals and could have detrimental effects on society. They highlight the health risks for donors, citing studies that show increased likelihood of kidney failure and complications post-surgery. The speaker also points out the moral limits of markets and the corrosive effect of commercializing organ donation, emphasizing the importance of maintaining the altruistic nature of the act.

05:01

💼 The Consequences of Commercializing Organ Donations

This paragraph delves into the implications of treating organs as commodities, including the potential for dishonesty in donor medical history and the ethical concerns of incentivizing risky behavior. The speaker discusses the ineffectiveness of paid systems, as seen in countries like Iran, and the coercive nature of organ sales, particularly affecting the poor and vulnerable. They also address the complexity of legal and financial aspects surrounding organ sales, such as who would receive compensation in the event of a donor's death.

10:06

🙅‍♀️ Opposing the Legal Sale of Organs as an Unethical Market

The speaker concludes by reinforcing the argument that the legal sale of organs is unethical and should be opposed. They emphasize that payment for organs commodifies a precious gift and undermines the altruistic spirit of organ donation. The speaker suggests alternative solutions to address the organ shortage, such as focusing on preventative healthcare to reduce the need for transplants. They also draw parallels with other societal values, noting that certain honors and achievements cannot be bought, and neither should organs be.

Mindmap

Keywords

💡Organ sale

Organ sale refers to the practice of buying and selling human organs for transplantation. In the video, the speaker argues against legalizing organ sale, stating that it would not achieve its intended ends and would have a corrosive effect on attitudes towards organ donation. The script mentions that there are moral limits to markets and that organ sale is beyond that limit.

💡Donor task force

A donor task force is a group assembled to address issues related to organ donation, such as increasing donation rates. The speaker was a member of such a task force in Britain, which aimed to improve infrastructure and increase transplant rates, resulting in a 50% increase in transplanted organs.

💡Kidney donors

Kidney donors are individuals who donate one of their kidneys, typically to someone in need of a transplant. The script discusses the health implications for kidney donors, noting that they are more likely to end up in kidney failure compared to those with both kidneys, and that many have complications or psychological problems after surgery.

💡Commodification

Commodification refers to the process of treating something as a commodity, which can be bought and sold. The speaker argues that treating organs as commodities, as would occur with organ sale, is problematic because it changes behaviors and attitudes, potentially leading to dishonesty and exploitation.

💡Coercion

Coercion is the act of forcing someone to do something against their will. In the context of organ sale, the script mentions that payment can lead to coercive situations, particularly for vulnerable populations, such as young women in poverty who may be pressured into selling their organs.

💡Dialysis

Dialysis is a medical procedure that removes waste products and excess fluids from the blood, typically used by individuals with kidney failure. The script discusses the potential long-term health consequences for kidney donors, who may eventually require dialysis or transplants themselves.

💡Transplantation

Transplantation is the medical procedure of moving an organ from one body to another to replace a failing organ. The video discusses the infrastructure improvements related to transplantation that have led to increased organ donation rates in Britain.

💡Market in organs

A market in organs refers to a system where organs are bought and sold. The speaker argues that such a market would not only fail to solve the problem of organ shortages but would also be unfair and lead to exploitation, as seen in the case of Iran, where payment for organs has not eliminated waiting lists.

💡Moral limits

Moral limits are boundaries that define what is considered ethical or acceptable behavior. The speaker asserts that there are moral limits to markets, and that the sale of organs crosses these limits, suggesting that some things, like organ donation, should not be subject to market forces.

💡Sugar tax

A sugar tax is a levy imposed on sugar-sweetened beverages, intended to reduce consumption and address health issues like diabetes. The script suggests that directing money towards preventative measures, such as a sugar tax, could be a more effective way to deal with organ waiting lists than paying for organ donations.

💡Gift aspect

The gift aspect refers to the notion of giving something without expecting anything in return. The speaker emphasizes that a paid market for organs devalues the gift aspect of organ donation, which is a precious and selfless act that should not be reduced to a mere transaction.

Highlights

Legalizing the sale of organs could have a negative impact on attitudes towards donation.

There are moral limits to markets, and the sale of organs may exceed those limits.

A 50% increase in transplanted organs in Britain was achieved through infrastructure improvements, not consent changes.

Kidney donors face health implications and a higher risk of kidney failure compared to those with both kidneys.

35% of kidney donors in the US are lost to follow-up, highlighting the lack of long-term monitoring.

Paying donors $45,000 for a kidney does not account for the future health costs they may incur.

20% of kidney donors experience complications after surgery, and 30% suffer psychological problems.

Commercializing transplants can lead to a transactional view of organs and potential dishonesty in medical history reporting.

The idea of selling organs could be extended to other organs, with significant risks and ethical concerns.

Payment for organs has no application for the majority of organs and does not address the root causes of organ failure.

The NHS would be financially burdened by the need to pay donors upfront, potentially restricting organ transplants.

In the UK, blood donations are sufficient without payment, unlike the mixed economy in the US which suffers shortages.

Iran, which has a payment system for organs, still experiences waiting lists and issues with coerced donations.

Payment for organs can be unfair and exploitative, particularly towards the poor and vulnerable.

A paid organ market reduces the value of the precious gift that is organ donation.

The speaker urges opposition to the motion of legalizing the sale of organs, citing ethical and practical concerns.

Transcripts

play00:01

[Music]

play00:06

[Music]

play00:16

ladies and gentlemen and students of

play00:18

Oxford in your third week of term can I

play00:22

just say hearing you cough I'm not

play00:24

having your

play00:26

lungs now I want to show you that LE

play00:30

legalizing the sale of organs would be a

play00:32

backward step that it would not achieve

play00:36

its intended ends it's a very limited

play00:38

application and that it would have a

play00:40

corrosive effect on attitudes to

play00:42

donation and I hope to make it apparent

play00:45

that there are moral limits to markets

play00:48

and that organ donation sale of organs

play00:51

is beyond that limit now I was a member

play00:54

of the organ Dona task force it was put

play00:57

together to try and increase donation

play00:59

rates in Britain which were appalling

play01:02

and I'm delighted to say that by a

play01:04

series of measures related to the

play01:06

Improvement of infrastructure not about

play01:09

consent about the infrastructure and

play01:10

transplantation there's been a 50%

play01:13

increase in transplanted organs I've got

play01:16

enormous sympathy for people on the

play01:18

waiting list I've met lots of those

play01:20

people I've interviewed many of them

play01:22

their courage their plight never fails

play01:25

to move

play01:26

me but we always highlight don't we the

play01:30

benefits to the recipients because of

play01:32

course they're in such a terrible state

play01:36

but we never

play01:39

really highlight the implications for

play01:42

the donors and I'm talking about the

play01:44

health implications we talk about

play01:46

kidneys oh we've got two you can do with

play01:49

just

play01:51

one it's like spare parts you've got a

play01:54

spare well I've got two arms ladies and

play01:56

gentlemen actually this one is not spare

play02:01

it doesn't mean that if you've got two

play02:02

that you can do without

play02:04

one now worldwide organs have been taken

play02:07

from living donors for over 60 years but

play02:11

Registries that uh record what happens

play02:14

to donors are less than 20 years old the

play02:17

UK has one it's only 15 years old as one

play02:21

kidney takes on the work of two it

play02:23

begins to scar and FiOS what it can cope

play02:26

with at the age of 25 or 40 even in good

play02:29

General Health begins to falter with the

play02:32

poorer circulatory health of old age and

play02:35

remember that a

play02:37

50-year-old we people in our Prime we

play02:40

expect to live at least another 30 or

play02:43

perhaps even 40

play02:46

years in the US where lots of the

play02:48

figures about donor Health come from 35%

play02:53

of kidneys donors are lost to followup

play02:56

but amongst those we know about compared

play02:58

to those with both kidneys kidney donors

play03:00

are 8 to 11 times more likely to end up

play03:03

in kidney failure in a jam that's a

play03:05

journal of American Medical Association

play03:07

paper in 2014 a followup of just seven

play03:11

years was already demonstrating an

play03:13

increased risk of kidney failure but

play03:16

it's okay right they were paid for their

play03:19

kidneys so

play03:21

tough in a paper in last month's

play03:23

American Journal of transplantation the

play03:25

costs are calculated of benefits of

play03:28

society of paying donors

play03:31

$45,000 each for kidney that was the

play03:33

kind of the cost benefit equipo

play03:36

elimination of the waiting list Savings

play03:37

of billions for society not a single

play03:40

mention not a mention and certainly no

play03:43

calculation of future costs of carrying

play03:45

for a generation of donors in 30 years

play03:48

time when lots of them are going to need

play03:51

dialysis and transplants and this is an

play03:53

illegal Market

play03:55

remember a a legal uh situation by the

play03:58

way no mention that 20% of kidney donors

play04:01

have complications after surgery or that

play04:03

30% suffer psychological problems many

play04:06

very severe so payment replaces one

play04:09

problem with another which has not been

play04:12

properly

play04:13

Quantified now let me tell you about the

play04:15

attitudes that go with commercializing

play04:17

transplants a month ago I was in

play04:19

Manchester I got talking to a taxi

play04:21

driver he was British he was 40 he had a

play04:24

young family his kidneys had failed just

play04:27

like his dad he was on dialysis three

play04:29

times a week very unusual tissue type

play04:32

chances of actually finding a donor

play04:35

pretty slim he thought he'd die on the

play04:37

waiting list just like his uncle back in

play04:40

Pakistan he said where his family came

play04:42

from I could get a kidney for

play04:44

£4,000 and they guarantee a 90% chance

play04:48

of

play04:49

success what if the Man donated it

play04:52

developed kidney failure and was in just

play04:54

the same state as you and he thought

play04:57

about that for a bit and he said well

play04:59

that his

play05:00

Lookout once you've paid money for a

play05:03

kidney it's a transaction like any other

play05:06

it's a commodity a kidney from a smoker

play05:09

do I get a discount does that earn the

play05:11

donor less a donor lies about their

play05:14

history can they be sued and if you

play05:17

really want and need the money there is

play05:20

much more incentive to lie about your

play05:22

medical past which isn't always

play05:25

available or obvious to doctors and I

play05:28

know you mentioned HIV I could agree to

play05:30

give my kidneys today I could sleep with

play05:33

six HIV positive men obviously all

play05:37

gorgeous uh tonight and actually no one

play05:42

would

play05:43

know Money Changes behaviors of course

play05:48

the idea of sale could only be

play05:49

considered for kidneys surely you

play05:51

wouldn't suggest it for a liver where

play05:53

there's a if you're a living donor

play05:54

there's a 1 in2 200 chance of death

play05:56

during surgery and a 40% complic ation

play06:00

rate in the UK right now there are 16

play06:03

children waiting for a heart transplant

play06:06

the UK has run out of what are called

play06:08

bridge to transplantation pediatric beds

play06:11

these children aren't going to be helped

play06:12

by a market in organs payment has no

play06:15

application for the majority of organs a

play06:18

market in children's Hearts oh please

play06:22

let's just change the law and sell

play06:27

children and of course we don't sell

play06:29

children children do we even though of

play06:31

course if you have them they're yours

play06:33

and you possibly can I've seriously

play06:36

considered selling mine

play06:39

sometimes but you don't because it would

play06:41

devalue their uh their the whole concept

play06:45

of children and if we were to pay the

play06:47

Sterling equivalent of that

play06:49

£30,000 that $45,000 which is about

play06:52

£30,000 to each of the 6,000 people on

play06:55

the kidney waiting list and remembering

play06:58

that the saving envisaged are years in

play07:01

the future the NHS would be bankrupted

play07:03

by the need to pay donors UPF front and

play07:06

organizations organization organ

play07:08

transplants rather would have to be

play07:09

restricted and of course it also ignores

play07:12

a fundamental truth that the best way to

play07:15

deal with a waiting list is to direct

play07:18

money to stop people getting diabetes

play07:21

which is the principal reason for kidney

play07:24

failure sugar tax

play07:27

please but let's stick with the UK

play07:29

figures at the moment each UK hospital

play07:32

that takes a kidney for transplantation

play07:34

is paid £22,000 which covers the

play07:36

expenses of doing so because they don't

play07:39

necessarily get benefit but there's a

play07:41

lot of cost attached to uh the

play07:44

surgery what if you switch that sum to

play07:47

the donor families if they agreed to

play07:49

donate at

play07:51

death who'd get the cash one of them all

play07:56

of them only the ones that agreed to the

play07:58

donation but not the ones who didn't

play08:01

what about the situation where you have

play08:03

a man and indeed my uh husband's uh

play08:06

father was uh died on the job um and he

play08:12

had his both his mistress and his wife

play08:15

turn up uh in accident and emergency

play08:19

ladies and gentlemen who gets the death

play08:21

money

play08:23

then what do legal sales in other areas

play08:26

of medicine tell us in the UK 40% of

play08:29

population give enough blood for all our

play08:31

transfusion needs for nothing but a cup

play08:34

of tea and a rich tea biscuit and if

play08:36

you're not from Britain a rich tea

play08:38

biscuit is a piece of sweetened

play08:40

cardboard in the US there's a mixed

play08:42

economy of paid and voluntary donations

play08:45

and their system suffers shortages ours

play08:48

does not and works much better here we

play08:51

allow payment for

play08:52

Seaman one off the wrist will earn you

play08:55

£3 35

play08:57

gentlemen however is is there a good uh

play09:00

lot of donors no there are just nine

play09:04

after a whole year of trying to attract

play09:07

donors what about Iran payment and no

play09:10

waiting list indeed remember that Iran

play09:13

has waiting lists just as long as we

play09:14

have for Heart and Lung and for liver

play09:17

and its population is much younger than

play09:19

ours their median age is uh 24 here it's

play09:21

over 40 fewer older people with kidney

play09:24

disease many younger fit people

play09:29

where the donors come from there in the

play09:31

Iranians say that 50% of those donors uh

play09:34

are in poverty they have a big issue

play09:36

with young women coerced into donation

play09:39

by their families and that's the most

play09:41

iniquitous aspect of payment for organs

play09:44

the unfairness and corrosive effect of a

play09:46

market in something which should not be

play09:49

commoditized when someone when all

play09:52

someone has is their health is it right

play09:55

that they are paid to give it away

play09:57

especially when for many the require

play09:59

healthy lifestyle following donation is

play10:05

unattainable in principle I defend the

play10:08

right of women to sell their bodies but

play10:10

in practice it's coercive exploitative

play10:13

of the poor and vulnerable and leads to

play10:15

trating and all sorts of crimes organ

play10:18

donation is the same more than that a

play10:20

paid for Market reduces the value of the

play10:23

precious gift that's an organ

play10:27

donation that me in in summary I hope

play10:30

I've shown you that the payment replaces

play10:32

one problem with another has no

play10:34

application for the majority of organs

play10:36

that paid for systems manifestly don't

play10:39

work and that payment is unfair and

play10:41

corrosive of the gft aspect you cannot

play10:44

buy a place at Oxford you can't buy a

play10:47

Nobel Prize you can't buy friends the

play10:51

legal sale of organs falls into that

play10:53

same category and I urge you to oppose

play10:56

this motion

play10:59

than

play11:11

[Music]

Rate This

5.0 / 5 (0 votes)

Ähnliche Tags
Ethical DebateOrgan DonationHealthcare PolicyMarket MoralsMedical EthicsDonor RisksLegal ControversySocial ImpactHealth EconomicsTransplantation Issues
Benötigen Sie eine Zusammenfassung auf Englisch?